# Real-World Application for Innovation and Development

Canonical: https://abierto.us/opportunities/fdassn75f40125q00029

- Solicitation number: FDA-SSN-75F40125Q00029
- Notice type: Sources sought
- Status: Closed. Deadline was February 11, 2025 at 12:00 PM EST
- Department: Department of Health and Human Services
- Agency: Food and Drug Administration
- Contracting office: FDA Office of Acq Grant SVCS (75F401)
- NAICS: 541512 Computer Systems Design Services
- Product or service code: DB01 Support services for specialized High Performance Computing (HPC) systems used in solving complex computational problems through massive concurrent use of computing resources and parallel processing techniques.
- Set-aside: Total small business set-aside
- Place of performance: Silver Spring, Maryland
- County: Montgomery County (FIPS 24031). https://abierto.us/counties/montgomery-county-md-24031
- City: Silver Spring. https://abierto.us/cities/silver-spring-md-2472450
- First posted: January 21, 2025
- Last posted: January 21, 2025
- SAM.gov: https://sam.gov/workspace/contract/opp/92aaebdd080e4f7595b932e0a6004816/view

## Description

The U.S. Food and Drug Administration (FDA) is issuing this source sought notice as a means of conducting market research, pursuant to FAR Part 10 Market Research, to identify viable industry parties capable of supporting FDA’s Real-World Application for Innovation and Development (RAPID), enhancement of the current AWS platform, development of new applications prototypes and Proof of Concepts.

The mission of CDER’s Office of Computational Science (OCS) is to modernize the Center’s regulatory review process and enable reviewers to spend less time dealing with complex data and more time applying their expertise to information through the use of integrated tools, services, and training. OCS’ efforts to accomplish this mission involve developing technology and analytics to support regulatory review work.

RAPID was developed as a means to implement a cloud-based and on-premises environment to develop and continuously improve the applications and databases needed to meet the innovation and analytical needs of FDA users.

The RAPID platform is capable of supporting a variety of cloud and other operations including, supporting individual regulatory research, ingest, evaluate, and validate new analytic tools and methodologies, support new methods of multi data base curation, characterization and integration for transdisciplinary analysis of complex and big data, and a range of artificial intelligence tools and use cases for FDA needs.

RAPID is a sandbox that promotes the development of innovative analytic tools, supports data science research, and the evaluation of cutting-edge technologies. The RAPID System in its current form uses Artificial Intelligence (AI) and cloud-based compute facilities to develop innovative analytical solutions that support regulatory decision making and scientific analysis.

Refer to the National Academies of Sciences “Convergence”, https://www.nae.edu/113283.aspx, report to get an understanding of what ”transdisciplinary FDA scientific need” must include.

## Publications

- January 21, 2025: Sources sought, due February 11, 2025 at 12:00 PM EST. Notice 92aaebdd080e4f7595b932e0a6004816. https://sam.gov/workspace/contract/opp/92aaebdd080e4f7595b932e0a6004816/view

## Points of contact

- Noah Padilla, Noah.Padilla@fda.hhs.gov

---
Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/fdassn75f40125q00029.